N,N-bis(pyridin-2-ylmethyl)-1-[4-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine
C36H47N7 — CID 155562602
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-bis(pyridin-2-ylmethyl)-1-[4-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine
N,N-bis(pyridin-2-ylmethyl)-1-[4-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine (PubChem CID 155562602) has the molecular formula C36H47N7 and a molecular weight of 577.82 g/mol. Its IUPAC name is N,N-bis(pyridin-2-ylmethyl)-1-[4-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine.
Molecular Properties
| Compound Name | N,N-bis(pyridin-2-ylmethyl)-1-[4-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine |
|---|---|
| PubChem CID | 155562602 |
| Molecular Formula | C36H47N7 |
| Molecular Weight | 577.82 g/mol |
| Exact Mass | 577.39 |
| IUPAC Name | N,N-bis(pyridin-2-ylmethyl)-1-[4-[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]phenyl]methanamine |
| SMILES | c1ccc(CN(Cc2ccc(-c3ccc(CN4CCCNCCNCCCNCC4)cc3)cc2)Cc2ccccn2)nc1 |
| InChI | InChI=1S/C36H47N7/c1-3-20-40-35(7-1)29-43(30-36-8-2-4-21-41-36)28-32-11-15-34(16-12-32)33-13-9-31(10-14-33)27-42-25-6-19-38-23-22-37-17-5-18-39-24-26-42/h1-4,7-16,20-21,37-39H,5-6,17-19,22-30H2 |
| InChIKey | DNDGMRHMHQSQFK-UHFFFAOYSA-N |
| XLogP | 4.71 |
| TPSA | 68.35 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 577.82 |
| LogP ≤ 5 | 4.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155562602 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.